ARTICLE | Company News
Cogent, Elan in neurological deal
March 8, 2001 8:00 AM UTC
Cogent Neuroscience (Durham, N.C.) and ELN will collaborate to discover therapeutic gene targets to treat Huntington's disease and other polyglutamine repeat diseases. The collaboration will use Cogen...